David C. Foster, Ph.D. is a partner and registered patent attorney with more than 15 years of diverse experience working with technology companies developing and implementing world-wide patent strategies. David began his career in the San Francisco Bay Area, representing emerging technology companies, public companies, universities and venture capital investors, with a particular emphasis on biotechnology clients. His practice involves a comprehensive intellectual property strategy, from patent application drafting and prosecution, to technology transactions and IP landscape analyses.
Prior to founding Roberts Foster LLP, David worked as both in-house patent counsel at a biotherapeutic development company and in international law firms in California and Texas. In addition, David co-founded and serves as general counsel for a clinical-stage biotherapeutic company focused on developing treatments for neurological disorders.
- Golden Gate University School of Law, J.D., 2003 (IP Law Specialization Certificate)
- The University of Texas Southwestern Medical Center, Ph.D., Biomedical Research, 1997
- The University of North Texas, B.S., Biology, 1990
- American Society for Biochemistry and Molecular Biology Young Scientist’s Travel Fellowship, 1997
- NIH Fellow-Cell and Molecular Biology Training Grant, 1995
- Member, State Bar of Texas
- Member, State Bar of California
- Registered Patent Attorney, United States Patent and Trademark Office (Reg. No. 44,685)
Select Patents & Publications
- WO/2013/086133 – Methods and compositions for treating viral disease
- WO/2013/074911 – Blue-light inducible system for gene expression
- 7,709,607 -Adiponectin variants
- 7,678,886 – Pharmaceutical compositions of adiponectin variants and methods of storage
- 6,890,764 – Encoding and decoding of array sensors utilizing nanocrystals
- 6,667,159 – Optical fiber biosensor array comprising cell populations confined to microcavities
- 6,472,144 – High throughput screening method and apparatus
- California Decision Clarifies Common-Sense Obviousness- IP Law360, June 18, 2013
- Foster, D.C., Wedel, B.J., Robinson, S., and Garbers, D.L. (1999) Mechanisms of regulation and functions of guanylyl cyclases. Rev Physiol Biochem Pharmacol. 135:1-39.
- Foster, D.C., and Garbers, D.L. (1998) Dual Role for Adenine Nucleotides in the Regulation of the Atrial Natriuretic Peptide Receptor, Guanylyl Cyclase-A. J. Biol. Chem. 273:16311-16318.
- Foster, D.C., Garbers, D.L., and Wedel, B.J. (1997) The Guanylyl Cyclase-A Receptor In: Contemp. Endocrin. edited by P.M. Conn, The Humana Press Inc.
- Wedel, B.J., Foster, D.C., Miller, D.E. and Garbers, D.L. (1997) A Mutation of The Atrial Natriuretic Peptide (Guanylyl Cyclase-A) Receptor Results In a Constitutively Hyperactive Enzyme. Proc. Natl. Acad. Sci. USA 94:459-462.
- Wong, S.K.F., Ma, C.P., Foster, D.C., Chen, A.Y. and Garbers, D.L. (1995) The Guanylyl Cyclase-A Receptor Transduces an Atrial Natriuretic Peptide/ATP Activation Signal in the Absence of Other Proteins. J. Biol. Chem. 270:30818-30822.
- Fulle, H.J., Vassar, R., Foster, D.C., Yang, R.B., Axel, R. and Garbers, D.L. (1995) A Receptor Guanylyl Cyclase Expressed Specifically in Olfactory Sensory Neurons. Proc. Natl. Acad. Sci. USA 92:3571-3575.
- Yang, R.B., Foster, D.C., Garbers, D.L. and Fulle, H.J. (1995) Two Membrane Forms of Guanylyl Cyclase Found in the Eye. Proc. Natl. Acad. Sci. USA 92:602-606.
- Smart, E.J., Foster, D.C., Ying, Y.S., Kamen, B.A. and Anderson, R.G.W. (1994) Protein Kinase C Activators Inhibit Receptor-Mediated Potocytosis by Preventing Internalization of Caveolae. J.Cell Biol. 124:307-313.
- Cell Regulation Graduate Program Dissertation: “In vitro Analysis of Mechanisms Regulating the Atrial Natriuretic Peptide Receptor, Guanylyl Cyclase-A”
1400 Civic Place, Suite 221
Southlake, TX 76092